These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 17584499

  • 1. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
    Nanni C, Zamagni E, Cavo M, Rubello D, Tacchetti P, Pettinato C, Farsad M, Castellucci P, Ambrosini V, Montini GC, Al-Nahhas A, Franchi R, Fanti S.
    World J Surg Oncol; 2007 Jun 20; 5():68. PubMed ID: 17584499
    [Abstract] [Full Text] [Related]

  • 2. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
    Nanni C, Rubello D, Zamagni E, Castellucci P, Ambrosini V, Montini G, Cavo M, Lodi F, Pettinato C, Grassetto G, Franchi R, Gross MD, Fanti S.
    In Vivo; 2008 Jun 20; 22(4):513-7. PubMed ID: 18712181
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT.
    Ak İ, Onner H, Akay OM.
    Ann Hematol; 2015 Sep 20; 94(9):1567-75. PubMed ID: 26068066
    [Abstract] [Full Text] [Related]

  • 5. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
    Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D, Salizzoni E, Canini R, Cavo M, Fanti S.
    Eur J Nucl Med Mol Imaging; 2006 May 20; 33(5):525-31. PubMed ID: 16453155
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
    Golan S, Sopov V, Baniel J, Groshar D.
    J Urol; 2011 Aug 20; 186(2):436-41. PubMed ID: 21679983
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M.
    J Nucl Med; 2008 Feb 20; 49(2):195-200. PubMed ID: 18199607
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Value of FDG PET in the assessment of patients with multiple myeloma.
    Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R.
    AJR Am J Roentgenol; 2005 Apr 20; 184(4):1199-204. PubMed ID: 15788594
    [Abstract] [Full Text] [Related]

  • 12. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
    Nuñez R, Macapinlac HA, Yeung HW, Akhurst T, Cai S, Osman I, Gonen M, Riedel E, Scher HI, Larson SM.
    J Nucl Med; 2002 Jan 20; 43(1):46-55. PubMed ID: 11801702
    [Abstract] [Full Text] [Related]

  • 13. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V.
    Clin Exp Med; 2015 Feb 20; 15(1):1-18. PubMed ID: 25218739
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.